The present study was envisaged to evaluate the effect of erlotinib β-cyclodextrin
nanosponge (ERL-NS) on the solubility, dissolution, in vitro cytotoxicity and oral …

The aim of the study was to investigate the impact of erlotinib sulfobutyl ether beta-
cyclodextrin complex (ERL-SBE-β-CD) on ERL dissolution rate and oral bioavailability …

Systemic and uncontrolled administration of erlotinib hydrochloride (ETB) is associated with
severe toxicity. A novel targeted and extended release nanosponge (NS) was synthesized …

This study was aimed at developing a nanoparticle strategy to overcome acquired
resistance against erlotinib in non-small cell lung cancer (NSCLC). To load erlotinib on …

The present investigation demonstrates the preparation of solid self nanoemulsfying drug
delivery system (sSNEDDS) to enhance stability and bioavailability of Erlotinib (ERL) via the …

To improve the solubility and oral bioavailability of erlotinib, a poorly water-soluble
anticancer drug, solid self-emulsifying drug delivery system (SEDDS) was developed using …

Background Bortezomib (BTZ) as an anticancer drug has been used through the injection
pathway. Research design and methods Two types of Cyclodextrin nanosponges (CDNSs) …

Smart drug delivery systems are required for the site-specific drug targeting to enhance the
therapeutic efficiency of a drug. Resveratrol (RV) is a polyphenolic compound with anti …

Anionic biopolymer (sodium alginate/low-methoxyl pectin/gellan gum) coated carboxymethyl
pullulan-ZnO nanocomposites encapsulating erlotinib were developed for lung cancer …

Cyclodextrin complex of nintedanib was prepared aiming for increased bio-activity and
improved transport across intestinal membrane with reduced p-glycoprotein (p-gp) efflux …